GlassScriptPhysician profile
Janet Benton
NPI 1114039161
$3,608.70
in general payments reported to CMS, 2019-2025
20 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $988 · 2023: $695 · 2024: $691 · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,357 · Education: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,357.12 |
| Education | $263.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $766.14 | 2022-2025 | |
| Janssen Biotech, INC. | $593.83 | 2022-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $368.52 | 2022-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $247.14 | 2024-2025 | |
| Genzyme Corporation | $228.23 | 2022-2025 | |
| Dermavant Sciences, INC. | $223.81 | 2022-2024 | Vtama |
| Leo Pharma INC. | $188.86 | 2022 | |
| Pfizer INC. | $184.46 | 2022-2025 | |
| Incyte Corporation | $184.31 | 2022-2025 | Opzelura |
| Lilly USA, LLC | $172.63 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $138.02 | 2022-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $74.60 | 2022-2023 | Blu-U, Odomzo |
| Almirall LLC | $62.87 | 2022-2025 | Klisyri |
| Ucb, INC. | $48.17 | 2024-2025 | Bimzelx |
| Medimetriks Pharmaceuticals, INC. | $36.31 | 2022-2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.69 | 2025 | Otezla |
| Kyowa Kirin, INC. | $19.37 | 2023 | Poteligeo |
| Arcutis Biotherapeutics, INC. | $18.79 | 2024 | Zoryve |
| Sebela Pharmaceuticals INC. | $18.53 | 2022 | |
| Botanix Sb INC | $14.42 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Benton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.